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Objective: Infectious diseases and anxiety disorders are common and both are associated
with substantial burden to individual, families, and society. A better understanding of their
association may be helpful in explicating possible etiological mechanisms related to both.
The goal of the current study was to investigate the relationship between specific infectious
diseases and anxiety disorders among adults in the community, and to examine whether
the co-occurrence of the two is associated with poorer quality of life compared to subjects
with one or neither condition.
Methods: We used data from the 1998 German Mental Health survey with 4181 subjects
aged 18–65. Various infectious diseases (lifetime) and health-related quality of life were
assessed via self-report questionnaires and anxiety disorders (past 12-months) were diagnosed using M-CIDI interviews. Logistic regression analyses were used to evaluate the
association between infectious diseases and anxiety disorders; a linear model adjusted for
sex was used to examine whether comorbidity of infectious diseases and anxiety disorders
was associated with quality of life.
Results: Whooping cough [odds ratio (OR) = 1.69, 95% confidence intervals (CI) = 1.36–
2.09], scarlet fever (OR = 1.31, 95% CI = 1.02–1.68), and diphtheria (OR = 1.79, 95%
CI = 1.21–2.64) were associated with increased prevalence of any anxiety disorder. Subjects
with both infectious diseases and anxiety disorders reported lower levels of both mental
and physical quality of life, compared with subjects with only one or neither condition.
Conclusion: Extending prior research, this study suggests a relationship between specific infectious diseases and anxiety disorders in an adult community sample. Research
targeting etiological mechanisms related to the interplay between infectious diseases and
anxiety disorders is warranted.
Keywords: representative survey, anxiety disorder, comorbidity, infectious diseases, quality of life

INTRODUCTION
Approximately 26% of the total global burden of disease is attributable to infectious diseases (1). Studies have also revealed that
mental disorders are a leading contributor to the total all cause
burden of disease worldwide (2, 3). Such rates render the refined
understanding, treatment, and prevention of both infectious disease and mental disorders as important public health goals. Toward
this end, it is crucial to understand etiological pathways involved
in disease and associated burden. Importantly, increasing evidence
points to associations between some infectious diseases and mental
disorders that may hint at overlapping etiologic pathways.
Major depressive disorder is associated with streptococcal infections (4). Further, severe infections such as hepatitis infections or
sepsis infections are associated with subsequent mood disorder
diagnosis in a longitudinal study (5). In addition, studies have
shown that pre-natal exposure to viruses increases the offsprings
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risk of unipolar affective disorder (6). Due to the association
of infectious diseases and affective disorders, there have been
efforts to detect potential etiological mechanisms related to both
infectious diseases and affective disorders (7, 8).
While much is known about infectious disease and mood disorders, relatively little has been done to investigating the possibly link
between infectious disease and anxiety disorders. Some research
findings suggest that infectious diseases could be related to the
development of specific anxiety disorders. Among infectious diseases, childhood group A streptococcal infections appear to be
associated with obsessive–compulsive disorder and/or tic disorders (pediatric autoimmune neuropsychiatric disorders associated
with streptococcal infection or PANDAS) (9) based on the results
of several studies. Other studies have found increased prevalence rates of posttraumatic stress disorder in HIV positive subjects across different demographic, cultural, and socioeconomic
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backgrounds (10). Additionally, anxiety disorders are associated
with inflammatory markers such as C-reactive protein in men
(11) and were found to be associated with having experienced
a common cold during the last 12 months compared to subjects
without (12). Furthermore, it was found that in older subjects
with cytomegalovirus (CMV) antibodies, individuals with higher
CMV specific antibody titers were more likely to be anxious than
subject with lower CMV antibodies (13). A cross-sectional study
looking at the association of infections in the first year of life
(reported by the parents) and anxiety disorders found that there is
an association between having any infection during the first year
of life and anxiety disorders (14). However, no differentiation was
made between different types of infections in this study. Additionally, very small cell sizes prohibited more informative analyses
(14). No prior study has examined the relationship between anxiety disorders and specific infectious disease among adults in the
community.
Additionally, research has shown that the comorbidity of anxiety disorders and physical health problems such as chronic physical
diseases is related to a decrease in health-related quality of life
(15). To date, no study has investigated whether the comorbidity between infectious diseases and anxiety disorders is associated
with an excess loss of health-related quality of life.
The goal of the current study was to investigate the relationship
between infectious diseases and anxiety disorders in a larger crosssectional sample of adults in the community. We also investigated
whether comorbidity of anxiety disorders and infectious disease is
associated with an excess loss of health-related quality of life.

MATERIALS AND METHODS
DESIGN AND SAMPLE

Data were drawn from the German Health Interview and Examination Survey and its Mental Health Supplement (GHS-MHS)
conducted in 1997. The German Health Survey (GHS) was the
first nationwide cross-sectional study for medical and social assessments in Germany, commissioned by the German Ministry of
Science, Research and Education, and the Robert Koch Institute
and authorized by the relevant institutional review board and
ethics committee. The aim of the core study was the assessment of
sociodemographic characteristics, physical diseases, impairments,
and healthcare utilization in a representative community sample of
7124 subjects aged 18–79 (Overall Response Rate: 61.5%). It was a
stratified, randomized sample from 113 communities throughout
Germany with 130 sampling units (sampling steps: 1: selection of
communities, 2: selection of sampling units, 3: selection of inhabitants) (16, 17). To handle the stratified sampling design the data
were weighted and confidence intervals (CI) were calculated by
the Huber–White sandwich method to account for the weighting
scheme as well as the stratified sampling design (16).
For the assessment of mental disorders in the GHS-MHS a twostage design was used: The first stage entailed the administration
of a 12-item screening questionnaire for mental disorders at the
end of the medical examination of the core survey (CID-S) (18).
The second stage involved the administration of a structured psychopathological interview, the Munich Composite International
Diagnostic Interview (DIA-X/M-CIDI) to all core survey respondents who had been screened positive for a mental disorder and to a
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random sample of 50% who screened negative (18). This subsample of the GHS built the sample of the Mental Health Supplement
and included 4181 subjects aged 18–65 years. The conditional
response rate (i.e., subjects who completed the M-CIDI interview)
was 87.6%. All participants gave their informed consent. Further
description of aims, design, and methods as well as sociodemographic characteristics of the whole GHS-MHS sample can be
found elsewhere (16).
MEASURES

Mental disorders

For the diagnostic assessments, a modified version of the fully
structured interview DIA-X/M-CIDI was used (19). The questions
cover DSM-IV and ICD-10 criteria. The DIA-X interview enables
the assessments of symptoms, syndromes and onset, duration, and
severity. The interview was conducted by trained psychologists and
physicians (20). The DIA-X/M-CIDI diagnostic algorithms were
used to obtain diagnostic findings reported in this paper (21). The
test–retest reliability of the DIA-X/M-CIDI was substantial (kappa
values ranging between 0.56 and 0.81) (20) and the sensitivity of
the DIA-X/M-CIDI diagnoses ranges from 87.5 to 100%; and their
specificity from 71.2 to 100% (22). Analyses revealed that the validity of the full diagnoses ranges from moderate to excellent when
compared to diagnoses administered from independent treating
physicians in a sample of randomly chosen patients (22).
The present study used the following 12-months DSM-IV
mental disorders: agoraphobia, social phobia, specific phobia
(animal, natural environment, blood–injection–injury, situational
type), panic disorder, generalized anxiety disorder, and obsessive–
compulsive disorder. We also included panic attacks during the
last 12 months.
Infectious diseases

Subjects were queried via a paper–pencil questionnaire: “which of
the following infectious diseases did you have during your lifetime:
diphtheria, whooping cough, measles, mumps, rubella, chicken
pox, scarlet fever, tuberculosis, dysentery, or typhus?”
Quality of life

We used the German version (23) of the well-validated (24–26) SF36 quality of life questionnaire. The SF-36 assesses health-related
quality in eight dimensions during the past 30 days (physical
functioning, social functioning, role limitations due to physical problems, bodily pain, mental health, role limitations due to
emotional problems, vitality, and general health). Principal component analysis revealed two robust factor dimensions of physical
and mental health: the Physical Component Score (PCS) and the
Mental Component Score (MCS) (27).
STATISTICAL ANALYSES

Association between infectious diseases and anxiety disorders

We used logistic regression analyses [odds ratio (OR) with 95%
CI] to examine associations between infectious diseases (yes/no,
the predictors in the model) and anxiety disorders (yes/no, the outcome in the model). We considered a p value <0.05 as statistically
significant. As the analyses revealed that there was an association
between both anxiety disorders and infectious diseases and sex

July 2014 | Volume 2 | Article 80 | 2

Witthauer et al.

the models were controlled for sex. We additionally built a variable called any anxiety disorder, which includes any of the anxiety
disorders. As we had additional lifetime information for panic
disorder and panic attacks, we checked for an association of these
variables with infectious diseases.
We further tested whether subjects with one or more than
one anxiety disorder report more infectious diseases than subjects
without any anxiety disorder. As the assumptions (homoscedasticity and normality) were fulfilled, we set up a linear model with the
number of anxiety disorders (three categories: none, one, and more
than one disorder) as independent variable and the mean number
of infectious diseases (ranging from zero to nine) as dependent
variable. In all analyses, sex was included as covariate. For all
analyses, we used the STATA software package, version 11.0 (28).
Association between comorbidity and quality of life

To analyze the association between anxiety disorders and infectious diseases and quality of life we used the two variables anxiety
disorder (including any of the anxiety disorder) and infections
(including any of the infectious diseases), both having two levels
(yes/no). We combined these two variables and built a factor with
four levels: one level with subjects with no infection and no anxiety disorder, one with only infection and no anxiety disorder, one
with no infection but with anxiety disorder, and one level with
both anxiety disorder and infection. To examine the association
between this factor and the dependent variable, the PCS and MCS
of the SF-36, we used a linear model with sex as covariate. For all
analyses, we used the STATA software package, version 11.0 (28).

RESULTS

Anxiety and infections

As shown in Figure 1, having one or more anxiety disorders was
associated with an increased number of infectious diseases compared to no anxiety disorder (mean number of infectious diseases
with no anxiety disorder: 2.42, 95% CI = 2.36–2.48; one anxiety disorder: 2.76; 95% CI = 2.60–2.91; two or more: 2.75; 95%
CI = 2.51–2.99, z = 2.76, p < 0.006). Contrast analysis in addition
showed that having more than one anxiety disorder did not further increase the number of infectious diseases relative to having
one anxiety disorder (z = 0.26, p < 0.798).
ASSOCIATION OF COMORBIDITY AND QUALITY OF LIFE

As shown in Figure 2, subjects with both infectious disease and
anxiety disorders report a lower level in the MCS (M = 43.6, 95%
CI = 42.5–44.7) than subjects with only infectious disease (51.6,
95% CI = 51.3–52.0, z = −14.23, p < 0.000) or neither of them
(M = 50.5, 95% CI = 49.1–52.0, z = −7.32, p < 0.000). In the PCS
subjects with only anxiety disorder (M = 42.3, 95% CI = 35.5–
48.0, z = −2.09, p < 0.037) and with both infectious disease
and anxiety disorder (M = 46.2, 95% CI = 45.2–47.1, z = −2.35,
p < 0.019) report a lower level when compared to subjects with
neither condition (M = 48.9, 95% CI = 47.2–50.7).
Additionally, subjects with only anxiety disorder (M = 42.3,
95% CI = 35.5–48.0) report a lower quality of life in the PCS
compared to subjects with only infectious disease (M = 49.6,
95% CI = 49.2–50.0, z = −2.48, p < 0.013). Further, subjects with
both anxiety disorder and infectious diseases (M = 46.2, 95%
CI = 45.2–47.1) report a lower quality of life in the PCS when
compared to subjects with only infectious disease (M = 49.6, 95%
CI = 49.2–50.0, z = −6.61, p < 0.000). All other comparisons were
not significant.

ASSOCIATION OF INFECTIOUS DISEASES AND ANXIETY DISORDERS

As shown in Table 1, most associations (five out of nine) were
found between whooping cough and 12-month anxiety disorders
[ORs ranging from 1.52 (95% CI = 1.15–2.00) for simple phobia
to 2.15 (95% CI = 1.36–3.40) for agoraphobia without panic disorder]. The associations between measles, rubella, chicken pox,
and anxiety disorders were not significant. Additionally, most
infectious diseases (4 out of 10) were associated with agoraphobia without panic disorder (ORs ranging from 1.79 (95%
CI = 1.06–3.00) for mumps and 2.61 (95% CI = 1.001–6.82) for
tuberculosis), whereas no associations between infectious diseases and phobic disorder not other specified, social phobia and
obsessive–compulsive disorder were found.
Whooping cough (OR = 1.69, 95% CI = 1.36–2.09), scarlet fever (OR = 1.31, 95% CI = 1.02–1.68), and diphtheria
(OR = 1.79, 95% CI = 1.21–2.64) were associated with having any
12-month anxiety disorder.
Additional analyses with lifetime diagnoses of panic disorder
and panic attacks and infectious diseases revealed that whooping cough (OR = 1.46, 95% CI = 1.02–2.07), typhus (OR = 4.24,
95% CI = 1.80–9.97), and diphtheria (OR = 2.39, 95% CI = 1.36–
4.21) were associated with panic disorder, whereas whooping
cough (OR = 1.42, 95% CI = 1.09–1.85), scarlet fever (OR = 1.37,
95% CI = 1.01–1.86), dysentery (OR = 2.41, 95% CI = 1.04–
5.56), typhus (OR = 2.62, 95% CI 1.21–5.66), and diphtheria
(OR = 2.25, 95% CI = 1.42–3.55) were associated with panic
attacks during lifetime.
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DISCUSSION
This study investigated the associations between infectious diseases and anxiety disorders in a representative adult community
sample. The results of this study suggest that specific infectious
diseases are associated with significantly increased prevalence of
anxiety disorders, compared with those without infectious diseases, and that the co-occurrence of the two is associated with
substantial loss in quality of life. Specifically, our findings revealed
associations between whooping cough, scarlet fever, and diphtheria and increased likelihood of having anxiety disorder. Additionally, associations between whooping cough, mumps, scarlet fever,
tuberculosis, dysentery, typhus, diphtheria, and specific anxiety
disorders were found. Our findings are partly in line with an earlier study suggesting an association between an infection in the
first year of life and panic disorder, social phobia, and overanxious
disorder (14). As in that study, we found associations of infectious diseases and anxiety disorders in general. In contrast, we did
not find an association between any of the investigated infectious
diseases and social phobia.
The findings are based on data from a representative community sample and therefore the results are not limited by the
same biases as in clinical samples. However, due to the crosssectional nature of this study, no conclusions concerning the
temporal sequence of infectious diseases and anxiety disorders
can be made. Therefore to explain the observed associations, three
different models will be considered.
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Table 1 | Odds Ratios of infectious diseases (lifetime) for anxiety disorders (12 months) compared to the reference group that had no indexed anxiety disorder during the past 12 months
(N = 4181).
DSM-IV mental

Whooping

Measles

Mumps

Rubella

Chicken pox

Scarlet fever

Tuberculosis

Dysentery

Typhus

Diphtheria

disorder

cough (n = 977,

(n = 2591,

(n = 2066,

(n = 1467,

(n = 2390,

(n = 632,

(n = 91,

(n = 52,

(n = 48,

(n = 181,

23.6%)

63.2%)

48.7%)

35.1%)

58.1%)

14.9%)

2.2%)

0.9%)

1.1%)

4.1%)

Any anxiety disordera
(n = 727, 14.5%)

1.69 (1.36–2.09)*
(n = 220)

1.00 (0.78–1.28)
(n = 458)

1.13 (0.92–1.40)
(n = 377)

0.96 (0.78–1.20)
(n = 265)

1.07 (0.84–1.36)
(n = 430)

1.31 (1.02–1.68)*
(n = 128)

1.51 (0.83–2.73)
(n = 18)

1.90 (0.86–4.18)
(n = 12)

1.17 (0.54–2.53)
(n = 11)

1.79 (1.21–2.64)*
(n = 49)

Panic disorder
with/without agoraphobia
(n = 121, 2.3%)

1.52 (0.97–2.34)
(n = 41)

0.68 (0.41–1.13)
(n = 73)

0.97 (0.62–1.52)
(n = 65)

0.91 (0.58–1.44)
(n = 46)

0.89 (0.54–1.45)
(n = 72)

1.08 (0.65–1.80)
(n = 25)

0.52 (0.07–3.87)
(n = 1)

0.82 (0.19–3.48)
(n = 2)

0.57 (0.07–4.31)
(n = 1)

2.82 (1.48–5.39)*
(n = 14)

Panic attack (n = 241,
4.7%)

1.49 (1.07–2.06)*
(n = 76)

0.91 (0.62–1.34)
(n = 149)

1.19 (0.85–1.66)
(n = 130)

0.97 (0.69–1.35)
(n = 89)

1.17 (0.79–1.72)
(n = 149)

1.29 (0.88–1.89)
(n = 47)

1.31 (0.52–3.34)
(n = 6)

1.21 (0.33–4.35)
(n = 4)

0.55 (0.13–2.36)
(n = 2)

2.46 (1.46–4.14)*
(n = 22)

Agoraphobia without
panic disorder (n = 105,
2.0%)

2.15 (1.36–3.40)*
(n = 42)

1.81 (0.91–3.60)
(n = 81)

1.79 (1.06–3.00)*
(n = 67)

1.12 (0.68–1.83)
(n = 42)

0.78 (0.45–1.33)
(n = 64)

1.97 (1.17–3.33)*
(n = 25)

2.61
(1.001–6.82)*
(n = 5)

2.71 (0.69–10.58)
(n = 4)

2.12 (0.55–8.13)
(n = 3)

1.93 (0.83–4.47)
(n = 8)

Simple phobia (n = 388,
7.6%)

1.52 (1.15–2.00)*
(n = 111)

0.80 (0.59–1.09)
(n = 244)

1.00 (0.76–1.30)
(n = 196)

1.03 (0.78–1.37)
(n = 146)

1.18 (0.86–1.67)
(n = 234)

1.18 (0.85–1.63)
(n = 65)

1.54 (0.70–3.39)
(n = 9)

1.15 (0.37–3.56)
(n = 4)

0.96 (0.31–2.96)
(n = 4)

1.50 (0.92–2.45)
(n = 26)

Phobic disorder NOS
(n = 173, 3.4%)

1.49 (0.99–2.24)
(n = 48)

1.01 (0.63–1.61)
(n = 110)

1.08 (0.73–1.60)
(n = 88)

0.86 (0.58–1.28)
(n = 61)

0.84 (0.55–1.28)
(n = 102)

1.08 (0.66–1.76)
(n = 26)

1.81 (0.57–5.73)
(n = 5)

2.88 (0.76–10.82)
(n = 3)

0.77 (0.17–3.38)
(n = 2)

1.56 (0.76–3.17)
(n = 10)

Social phobia (n = 94,
1.9%)

1.35 (0.80–2.27)
(n = 26)

1.71 (0.85–3.45)
(n = 55)

0.71 (0.43–1.18)
(n = 45)

0.82 (0.49–1.38)
(n = 33)

1.08 (0.56–2.10)
(n = 55)

0.64 (0.31–1.34)
(n = 10)

0.95 (0.21–4.17)
(n = 2)

–b

0.24 (0.03–1.77)
(n = 1)

1.36 (0.54–3.37)
(n = 6)

Generalized anxiety
disorder (n = 73, 1.5%)

1.94 (1.12 –3.35)*
(n = 28)

1.28 (0.64–2.54)
(n = 50)

1.28 (0.71–2.30)
(n = 37)

0.80 (0.44–1.45)
(n = 26)

1.40 (0.68–2.85)
(n = 45)

1.32 (0.67–2.60)
(n = 14)

1.41 (0.33–5.93)
(n = 2)

1.62 (0.21–11.97)
(n = 1)

–b

1.39 (0.31–6.53)
(n = 2)

Obsessive–compulsive
disorder (n = 38, 0.7%)

1.15 (0.53–2.49)
(n = 11)

0.82 (0.35–1.94)
(n = 25)

0.78 (0.34–1.76)
(n = 16)

0.95 (0.41–2.20)
(n = 13)

1.32 (0.51–3.38)
(n = 23)

1.10 (0.36–3.27)
(n = 5)

1.50 (0.32–6.80)
(n = 2)

–b

–b

2.16 (0.62–7.54)
(n = 3)

CI, confidence interval; DSM-IV, diagnostic and statistical manual of mental disorders, fourth edition; NOS, not other specified; OR, odds ratio; n, unweighted number of subjects, % weighted percentage, *p < 0.05,
a

including any anxiety disorder during the past 12 months.

b

empty cell size.
Anxiety and infections
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First, infectious diseases may precede anxiety disorders.
Through biochemical processes, infections may increase the risk
of having an anxiety disorder. Some infectious diseases such as
scarlet fever mainly have their first onset in early childhood (29),
whereas most anxiety disorders emerge for the first time during
puberty (17, 30). We might therefore suggest that some infectious
diseases do emerge before anxiety disorders do. This interpretation
may be supported by the findings of the above mentioned crosssectional study addressing the relationship of infectious diseases

FIGURE 1 | Mean number of infectious diseases (lifetime) for subjects
with no anxiety disorder, with one anxiety disorder, and with two or
more anxiety disorders (12 months). Mean scores adjusted for sex; n.s.
not significant, *p < 0.05, weighted data.

Anxiety and infections

and anxiety disorders, showing that severe infections during the
first year of life (reported by the parents) are associated with
increased anxiety disorders among 9–17-year olds, therefore suggesting that infections occur before anxiety disorders emerge
(14). Research suggests that increased concentration of proinflammatory cytokines could contribute to feeling of depression,
and also anxiety (13). Additionally, it is known that some viral
infections, such as tuberculosis, can directly affect the brain (31).
These processes may damage the brain and therefore cognitive
impairments and behavioral changes can occur (31). Cognitive
impairment in different domains such as executive functioning or
visual memory has been found to be common among people with
anxiety disorders (32) and is thought to reduce coping abilities
and impact social and occupational functioning (32), which could
lead to an intensification of anxiety symptoms.
Second, it may be that anxiety disorders precede infectious
diseases. One explanation for this path would be that anxiety disorders are related to psychological disturbance and stress. Stress is
associated with an increased cortisol secretion and may contribute
to an immune function decline. An immune function decline in
anxious subjects had been shown on a physiological level, namely
in a reduction of chemotaxis, phagocytosis, and lymphoproliferation (33). Alternatively, studies have shown that the extent and
quality of general medical health care among those with mental
disorders might be poor (31). Even though the association has
mainly been shown in psychotic and substance use disorders (31),
it may be that people with anxiety disorders receive less medical
information and therefore the frequency of vaccination could be
lower among these subjects leading to increased rates of some
infectious diseases.
Third, it may be that there is a common factor related to an
increased risk of having both infectious diseases and anxiety disorders at the same time. Both genetic and environmental common
factors could be considered. In our analyses, we found increased
rates of whooping cough, scarlet fever, dysentery, typhus, and

FIGURE 2 | The association of anxiety disorders and infectious diseases and health-related quality of life. Mean scores adjusted for sex.
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diphtheria in subjects with panic attacks. In prospective analyses, prior regular smoking was found to increase the risk of panic
attacks (34). Smoking on the other hand increases the risk of bacterial or viral infections (35). One might therefore speculate that
smoking could act as a common environmental risk factor for both
infectious diseases and mental disorders.
Our results also show that individuals with both conditions
have a loss in health-related quality of life. This is in line with earlier findings of those with anxiety disorders and chronic physical
diseases reporting decreased health-related quality of life (15). Our
analyses additionally show that infectious diseases are not associated with a significantly lower quality of life if they appear alone
when compared to people with neither condition. In combination
with anxiety disorders, however, they are. Our results therefore
extend previous findings and show that not only chronic physical diseases, but – at least partly – well treatable and time-limited
infections are related to lower quality of life in subjects with anxiety
disorders.
The current study has a number of limitations. First, the prevalence rates of the infectious diseases are based on self-report.
Therefore, it may be that some infectious diseases are misunderstood (e.g., whooping cough may be confused to cough in general
or may be overreported). Even though there is evidence suggesting that the validity of self-assessment of certain infectious diseases
such as a common cold is high (36), it is additionally known that
negative emotional style can be associated with an over-reporting
of unverified symptoms (reporting bias) (37). This needs to be
addressed in future studies by assessing infectious diseases with
medical interview or by laboratory blood tests. Second, the combination of infectious diseases and anxiety disorder led to some
small cell sizes, especially in tuberculosis, dysentery, typhus, and
diphtheria. Third, due to the cross-sectional nature of the study,
no conclusions can be drawn concerning the causal relationship
of the observed associations. Fourth, the results cannot be generalized to subjects younger than 18 and older than 65 years. Fifth,
we only had 12-month diagnoses for anxiety disorders (except for
panic disorder), whereas infectious diseases were assessed over lifetime. Future studies should address this issue by comparing both
infectious diseases and anxiety disorders during the same time
frame. Sixth, potential other confounders may play a role in the
associations.
With these limitations in mind, our study extends prior findings (14) about the association between infectious diseases and
anxiety disorders. Our study suggests that adults with infectious
diseases report higher prevalence rates of anxiety disorders and
that this comorbidity is associated with a health-related loss in
quality of life. Future longitudinal studies should clarify the temporal relationship of these disorders and evaluate the pathways
contributing to this comorbidity with targeted psychological and
immunological parameters. The health-related loss in quality of
life could underline the importance of disease prevention (e.g.,
vaccination) in people with anxiety disorders as especially subjects with both infectious disease and anxiety disorder reported
an impairment in quality of life. The associations additionally
show that infectious diseases and anxiety disorders might increase
the risk of having one another, and/or they might have common
shared risk factors at least in subtypes. This research could initiate
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future research on the linkage of infectious diseases and anxiety
disorders.
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